Brought to you by Physicians’ Education Resource®, LLC
Although multiple myeloma (MM) remains incurable, the past 15 years have yielded improved clinical outcomes with response rates rising as high as 30% with monotherapy and up to 90% with combination therapies. With new treatments that offer the potential to improve progression-free survival and overall survival for patients with MM in the relapsed/refractory setting, multidisciplinary care is a crucial element of support.
Oncology nurses are in a unique position in the multidisciplinary care team. Their frequent interaction with patients and caregivers ensures that patients will benefit from new clinical advances and receive the most appropriate supportive measures conducive to adherence and uninterrupted treatment.
Physicians’ Education Resource®, LLC, is partnering with oncology expert Charise Gleason, MSN, NP-BC, AOCNP, to present the live, CE-certified webcast, “Cases and Conversations™ in Multiple Myeloma: Nursing Considerations for Managing Relapsed/Refractory Disease” on Thursday, April 29, 2021.
The goal of this educational activity is to provide oncology nurses with the knowledge and competence to appropriately and safely incorporate new agents and regimens, thereby optimizing the treatment of their patients with relapsed/refractory MM throughout their disease course.
Hot topics to look forward to include:
- Review of new clinical trial data on emerging therapies for patients with relapsed/refractory MM
- Update on treatment-related toxicities
- Improved communication skills between health care teams and patients
Register for free to join PER® on Thursday, April 29 from 9:00 AM – 10:00 AM ET to continue your education and interact with oncology experts and fellow health care providers. For more information and to register, please visit: gotoper.com/go/ONS21MM.